• LAST PRICE
    5.3850
  • TODAY'S CHANGE (%)
    Trending Up0.2050 (3.9575%)
  • Bid / Lots
    5.3700/ 1
  • Ask / Lots
    5.4000/ 1
  • Open / Previous Close
    5.0100 / 5.1800
  • Day Range
    Low 4.9900
    High 5.4200
  • 52 Week Range
    Low 2.8600
    High 8.3100
  • Volume
    57,545
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 5.18
TimeVolumeVRCA
09:32 ET17005
09:35 ET4505.17
09:39 ET1005.21
09:42 ET10005.2927
09:44 ET4005.28
09:48 ET8005.295
10:02 ET2505.345
10:18 ET2005.39
10:22 ET2005.3165
10:31 ET1055.35
10:36 ET1005.31
10:40 ET1005.3
10:42 ET4145.29
10:44 ET4005.28
10:51 ET24005.3
11:02 ET1005.29
11:09 ET1005.28
11:21 ET1005.29
11:23 ET14005.32
11:25 ET109045.325
11:27 ET6005.3
11:32 ET1005.3037
11:34 ET1005.3
11:38 ET4005.3
11:39 ET5005.29
11:41 ET1005.25
11:43 ET4005.27
11:48 ET12005.3013
11:50 ET1005.3
11:56 ET1135.2756
11:57 ET2005.29
12:01 ET1455.2708
12:06 ET7755.29
12:08 ET1005.305
12:10 ET5005.32
12:14 ET81005.32
12:15 ET3005.32
12:17 ET1005.32
12:19 ET4005.31
12:21 ET1005.3025
12:24 ET75965.37
12:28 ET4005.38
12:30 ET1005.39
12:33 ET8005.38
12:39 ET6005.38
12:48 ET8005.38
12:50 ET14005.4
12:53 ET14005.38
12:57 ET1005.385
01:00 ET8005.4
01:02 ET1005.38
01:15 ET1005.36
01:18 ET1005.38
01:20 ET9005.39
01:22 ET4005.385
01:24 ET1005.385
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVRCA
Verrica Pharmaceuticals Inc
217.9M
-5.0x
---
United StatesSCPH
scPharmaceuticals Inc
203.0M
-4.4x
---
United StatesPBAJ
Petro USA Inc
200.1M
-6,250.0x
---
United StatesASPI
ASP Isotopes Inc
185.3M
-8.6x
---
United StatesTELO
Telomir Pharmaceuticals Inc
270.6M
-64.0x
---
United StatesBSEM
Biostem Technologies Inc
116.5M
0.0x
---
As of 2024-02-26

Company Information

Verrica Pharmaceuticals Inc. is a dermatology therapeutics company. The Company is focused on developing and commercializing treatments for skin diseases. Its product pipeline consists of three product candidates: VP-102, VP-315 and VP-103. The Company's lead product candidate, VP-102, is a drug-device combination that contains a GMP-controlled formulation of cantharidin which is being developed for potential use in treating molluscum contagiosum, a contagious and primarily pediatric viral skin disease; external genital warts (EGW), and common warts. Its second candidate, VP-315, is an oncolytic peptide-based injectable therapy for the potential treatment of dermatology oncologic conditions, including basal cell carcinoma, non-metastatic melanoma and non-metastatic Merkel cell carcinoma. The Company is also developing its second cantharidin-based product candidate, VP-103, for the treatment of plantar warts, which are warts located on the bottom of the foot.

Contact Information

Headquarters
10 N High St Ste 200WEST CHESTER, PA, United States 19380-3014
Phone
484-453-3300
Fax
302-636-5454

Executives

Chairman of the Board
Paul Manning
President, Chief Executive Officer, Director
Ted White
Chief Financial Officer
P. Terence Kohler
General Counsel, Company Secretary, Chief Legal Office
Christopher Hayes
Chief Commercial Officer
Joe Bonaccorso

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$217.9M
Revenue (TTM)
$3.2M
Shares Outstanding
42.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.87
EPS
$-1.07
Book Value
$0.97
P/E Ratio
-5.0x
Price/Sales (TTM)
68.0
Price/Cash Flow (TTM)
---
Operating Margin
-1,524.13%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.